BRPI0821406A2 - Matriz descelularizada de omento e uso da mesma - Google Patents

Matriz descelularizada de omento e uso da mesma

Info

Publication number
BRPI0821406A2
BRPI0821406A2 BRPI0821406-9A BRPI0821406A BRPI0821406A2 BR PI0821406 A2 BRPI0821406 A2 BR PI0821406A2 BR PI0821406 A BRPI0821406 A BR PI0821406A BR PI0821406 A2 BRPI0821406 A2 BR PI0821406A2
Authority
BR
Brazil
Prior art keywords
omentum
oment
decellularized
decellularized matrix
matrix
Prior art date
Application number
BRPI0821406-9A
Other languages
English (en)
Inventor
Chunlin Yang
Thoppil Mathew John
Anna Gosiewska
Charito S Buensuceso
David Colter
Agnieszka Seyda
Raymond Shissias
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of BRPI0821406A2 publication Critical patent/BRPI0821406A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/365—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Vending Machines For Individual Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0821406-9A 2007-12-19 2008-12-04 Matriz descelularizada de omento e uso da mesma BRPI0821406A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/960,010 US20090163990A1 (en) 2007-12-19 2007-12-19 Decellularized omentum matrix and uses thereof
PCT/US2008/085450 WO2009085547A2 (en) 2007-12-19 2008-12-04 Decellularized omentum matrix and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0821406A2 true BRPI0821406A2 (pt) 2015-06-16

Family

ID=40293881

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821406-9A BRPI0821406A2 (pt) 2007-12-19 2008-12-04 Matriz descelularizada de omento e uso da mesma

Country Status (9)

Country Link
US (1) US20090163990A1 (pt)
EP (1) EP2229191B1 (pt)
JP (1) JP5599722B2 (pt)
CN (1) CN101945676B (pt)
AT (1) ATE542553T1 (pt)
AU (1) AU2008343485B2 (pt)
BR (1) BRPI0821406A2 (pt)
CA (1) CA2709998A1 (pt)
WO (1) WO2009085547A2 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008109407A2 (en) 2007-03-02 2008-09-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Extracellular matrix-derived gels and related methods
US20110143429A1 (en) * 2008-04-30 2011-06-16 Iksoo Chun Tissue engineered blood vessels
JP2011519616A (ja) 2008-04-30 2011-07-14 エシコン・インコーポレイテッド 組織工学による血管
US20110165676A1 (en) * 2009-11-06 2011-07-07 The Children's Mercy Hospital Method for decellularization
WO2011087743A2 (en) * 2009-12-22 2011-07-21 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Decellularized adipose cell growth scaffold
JP2013165740A (ja) * 2010-05-14 2013-08-29 Waseda Univ 無細胞化方法及び人体移植用人工組織
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
JP5947790B2 (ja) * 2010-05-25 2016-07-06 クック・バイオテック・インコーポレイテッドＣｏｏｋ Ｂｉｏｔｅｃｈ Ｉｎｃｏｒｐｏｒａｔｅｄ 医療用移植片の細胞播種に有用な方法、基質、およびシステム
ES2935399T3 (es) 2011-01-06 2023-03-06 Humacyte Inc Constructos generados por ingeniería de tejidos
CA2830877A1 (en) * 2011-03-25 2012-10-04 Cooperlabs Limited Heat-extracted omentum extracts, compositions, methods of preparing and uses thereof
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
CN102266585B (zh) * 2011-07-20 2013-10-30 中国人民解放军第三军医大学第一附属医院 一种用于女性盆底的生物复合补片及其制造方法
CN102580140B (zh) * 2012-03-09 2013-11-06 潘银根 一种制备脱细胞生物膜敷料的方法
US8936651B2 (en) 2013-03-14 2015-01-20 Ethicon, Inc. Decellularized omentum matrix and uses thereof
US20140271904A1 (en) * 2013-03-15 2014-09-18 Cryolife, Inc. Methods for preparing tissue implants
US20160106886A1 (en) * 2013-05-20 2016-04-21 Ramot At Tel-Aviv University Ltd Metal-coated scaffolds for tissue engineering
WO2014207744A1 (en) 2013-06-24 2014-12-31 Ramot At Tel-Aviv University Ltd. Omentum based scaffold and delivery system
CA2919374C (en) 2013-07-30 2019-12-03 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
EP2832379B1 (de) * 2013-07-31 2015-07-22 Biotronik AG Verfahren zur Aufbereitung von biologischem Gewebe
US10987059B2 (en) 2013-11-17 2021-04-27 Ramot At Tel-Aviv University Ltd. Electronic scaffold and uses thereof
CN103656750B (zh) * 2013-12-07 2014-12-24 西南交通大学 一种在心血管植入材料表面改善多种仿生功能的方法
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
US10531957B2 (en) 2015-05-21 2020-01-14 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
CN104877956A (zh) * 2015-06-23 2015-09-02 华东医院 一种猪脂肪细胞外基质的提取工艺
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US10537665B2 (en) * 2015-09-11 2020-01-21 Lifecell Corporation Perforated tissue matrix
WO2017103930A1 (en) * 2015-12-16 2017-06-22 Ramot At Tel-Aviv University Ltd. Particles comprising decellularized omentum
CN108079363A (zh) * 2017-12-19 2018-05-29 广州昕生医学材料有限公司 一种用于动物组织脱细胞处理的试剂盒及其应用
CN108992709B (zh) * 2018-07-27 2021-05-14 山东省眼科研究所 一种脱细胞神经基质材料及其制备方法和应用
CN111110919A (zh) * 2019-12-30 2020-05-08 广东泓志生物科技有限公司 大网膜脱细胞基质材料的制备方法及软骨组织的构建方法
WO2021164626A1 (zh) * 2020-02-17 2021-08-26 杭州启明医疗器械股份有限公司 一种功能化生物基质材料及其制备方法和应用
CN111643734A (zh) * 2020-05-25 2020-09-11 内蒙古自治区中医药研究所 一种应用于半月板损伤修复的脱细胞基质
JP7781782B2 (ja) * 2020-05-29 2025-12-08 ロキット ヘルスケア インク． オメンタムを利用した腎臓治療用組成物、それを含む腎臓治療用医療キット、及び、その硬化物を含む腎臓治療用フィルム
KR102586304B1 (ko) * 2020-12-21 2023-10-11 주식회사 엘앤씨바이오 무세포 신경 이식재 및 그 제조방법
WO2023095149A1 (en) 2021-11-29 2023-06-01 Ramot At Tel-Aviv University Ltd. Methods and compositions for treating spinal cord injury
CN114246986B (zh) * 2021-12-29 2022-08-23 中国人民解放军陆军军医大学 一种基于原位调控免疫反应的心血管植入物及其制备方法
KR102763680B1 (ko) * 2022-01-12 2025-02-07 주식회사 이레텍코리아 식물성 복합 천연 계면활성제를 이용한 생체 삽입용 무세포 진피 기질 및 이의 제조방법
EP4626493A1 (en) 2022-11-29 2025-10-08 Matricelf Ltd. Methods for decellularizing human omentum and products generated therefrom
CN118370871B (zh) * 2024-06-24 2024-09-06 北京帝康医药投资管理有限公司 一种脱细胞生物网膜制备方法及由其制得的脱细胞生物网膜

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707369A (en) * 1984-02-23 1987-11-17 Faraday Laboratories, Inc. Process for treating wet fat biological tissue using a water miscible solvent
US4767746A (en) * 1985-12-04 1988-08-30 Trustees Of Boston University Method for enhancement of healing of epithelial wounds in mammals
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
US5336616A (en) * 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US6152142A (en) * 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US6734018B2 (en) * 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US8563232B2 (en) * 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
AU2001255741B2 (en) * 2000-04-28 2005-08-04 Baylor College Of Medicine Decellularized vascular prostheses
DE10064948C1 (de) * 2000-12-20 2002-07-11 Auto Tissue Gmbh Verfahren zur Dezellularisierung von Fremdmaterial zur Herstellung von Bioprothesen und Vorrichtung zur Durchführung des Verfahrens
CN1218755C (zh) * 2001-07-27 2005-09-14 北京科宇联合干细胞生物技术有限公司 一种干细胞再生表层角膜及其作为角膜移植材料的用途
WO2003011282A1 (en) * 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
CA2530732C (en) * 2003-06-27 2015-03-31 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
WO2005089823A1 (ja) * 2004-03-19 2005-09-29 Japan Science And Technology Agency 再生管腔臓器着生剤、着生可能型再生管腔臓器、着生可能型再生管腔臓器の製造方法、及び管腔臓器の再生着生方法
JP2005345196A (ja) * 2004-06-01 2005-12-15 Yamada Yoshihiko 超音波を使った脂肪組織の迅速処理法
EP1811933B1 (en) * 2004-09-28 2016-03-23 Atrium Medical Corporation Barrier layer
US20060171930A1 (en) * 2004-12-21 2006-08-03 Agnieszka Seyda Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
CN1903143A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工血管及其制备方法

Also Published As

Publication number Publication date
WO2009085547A2 (en) 2009-07-09
ATE542553T1 (de) 2012-02-15
WO2009085547A3 (en) 2010-04-15
AU2008343485B2 (en) 2013-08-22
JP2011507608A (ja) 2011-03-10
EP2229191B1 (en) 2012-01-25
US20090163990A1 (en) 2009-06-25
JP5599722B2 (ja) 2014-10-01
CA2709998A1 (en) 2009-07-09
EP2229191A2 (en) 2010-09-22
AU2008343485A1 (en) 2009-07-09
CN101945676A (zh) 2011-01-12
CN101945676B (zh) 2014-07-09

Similar Documents

Publication Publication Date Title
BRPI0821406A2 (pt) Matriz descelularizada de omento e uso da mesma
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
CR11731A (es) Composiciones y procedimientos para su preparación y uso
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
NI201100208A (es) Pirazinilpirazoles
BRPI0519298A2 (pt) mÉtodo de preparaÇço de um tecido biolàgico fixado
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
EP4403197A3 (en) Injectable formulations for organ augmentation
SG10201906304TA (en) Use of perfusion decellularized liver for islet cell recellularization
BRPI0922570B8 (pt) uso de uma preparação à base de água, biocompatível, de um kit, e, preparação à base de água, biocompatível
BR112012009039A2 (pt) métodos e dispositivos contraceptivos
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
EP2588592A4 (en) USE OF PERFUSION DECELLULARIZED ORGANS FOR AGGREGATE RECELLULARIZATION
BR112016015105A2 (pt) Conjugados var2csa-droga
MX2011011856A (es) Peliculas que contienen una mayor concentracion de zinc.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
ATE547130T1 (de) Biokompatibles implantat
BR112012005869A2 (pt) cristais da proteína a, cristais reticulados e métodos de utilização dos mesmos
BRPI1006875A2 (pt) composição farmacêutica, bactérias, uso de bactérias vivas, e, métodos para tratar um animal.
HN2009003466A (es) Herbicidas novedosos
UY31717A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas y su uso
AR068574A1 (es) Metodos para esterilizar lentes oftalmicas
BR112022003649A2 (pt) Inibidores conjugados de resposta ao dano no dna
CL2011001870A1 (es) Proceso de preparacion de un gel de fibrina autologo o desde sangre compatible para proliferacion y vehiculizacion celular; gel de fibrina o de sangre compatible; uso del gel de fibrina o de sangre compatible para uso quirurgico.
BRPI0921371A2 (pt) Células-tronco para uso terapêutico que são derivados de monócito humano, e método para induzir as mesmas.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]